ARCHIVES

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

October 15, 2004

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

Young Scientists Get Their Share Of NCI Grants

March 29, 1974

DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes

March 4, 1988

NSABP Operations Office Moves Across Town To Allegheny

December 13, 1996

NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute.

October 12, 2007